概括
这种Dictyostelium discoideum转位子DIRS-1,一个潜在的逆转位子,具有非相同的反向终端重复. 其保存的读取框架显示了对复原病毒逆转录酶的同质性,这表明了一个新的复制机制.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 生物信息学是一种生物信息学.
背景情况:
- 该Dictyostelium discoideum转位子DIRS-1具有独特的结构特征,包括非相同的反向终端重复 (ITR).
- 了解转子体的遗传元素和复制机制对于基因组稳定性和进化至关重要.
研究的目的:
- 描述DIRS-1转子子的内部序列和开放的读取 (ORF).
- 为了研究DIRS-1的保存阅读框架与已知的蛋白质的同质性.
- 根据其序列特征,提出DIRS-1复制模型.
主要方法:
- 对DIRS-1内部序列 (4158个核酸) 的生物信息分析.
- 三个开放式阅读框架 (ORF) 的识别和描述.
- 序列同质性搜索以确定保存的蛋白质域.
主要成果:
- DIRS-1编码了三个ORF,ORFs2和3是直线的和重叠的.
- 在DIRS-1元素的重叠区域观察到异常的序列保存.
- ORF3 含有 200 个氨基酸区域,同类于复原病毒逆转录酶.
结论:
- 根据逆转录酶同质性,DIRS-1被归类为可能的逆转录素.
- 建议使用其基因组RNA生成DNA副本的DIRS-1复制模型.
- 不相同的ITR建议采用一个独特的转移和整合机制.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
219
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
219
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
261
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261
siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
Small interfering RNAs (siRNA)
4.3K
No description available
4.3K
Hepatic Portal System
5.6K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.6K
Hepatic Drug Excretion: Influencing Factors
539
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
539